Furthermore, the effect of pharmacological inhibition of sEH in human blood vessels [25] as well as the association between EPHX2 sequence variants and risk of subclinical atherosclerosis has been published [26,27]. This evidence concerns the gene EPHX2 and atherosclerosis.